Yapay Zeka Hızlı Bakış & Çıkarımlar
AI InsightKey words: Bevacizumab, intestinal perforation, metastatic colorectal cancer
📌 3 Maddede Bu Makale
Özet
Bevacizumab is a monoclonal antibody which is targeting to vascular endothelial growth factor. It has been shown to be a promising drug on metastatic colorectal cancer and is combined with chemotherapeutic agents. One should be aware of serious complications even though bevacizumab is a well-tolerated drug. There are a few intestinal perforation cases that have been reported in the oncologic surgery literature related to the bevacizumab treatment. In this case report, we aimed to represent a 45 years old man who was diagnosed with intestinal perforation after bevacizumab treatment ten months after a metastatic colon cancer surgery. Key words: Bevacizumab, intestinal perforation, metastatic colorectal cancer